Loading…
Based on limited metadata, the FDA issued a Warning Letter to Massachusetts Institute of Technology on June 21, 2024, regarding biologics products or manufacturing practices. Without access to the full letter text or specific subject line, the precise nature of the violations cannot be determined from the available information. The warning falls under FDA biologics regulation, though the specific issuing office is not identified in the metadata provided. Further review of the complete Warning Letter would be necessary to identify the specific compliance issues cited.